Gamida Cell Ltd. Ordinary Shares
GMDA
GMDA was delisted on the 5th of April, 2024.
57 hedge funds and large institutions have $25.9M invested in Gamida Cell Ltd. Ordinary Shares in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and 8 closing their positions.
8% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 13
0% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 8
3% less funds holding
Funds holding: 59 → 57 (-2)
69% less capital invested
Capital invested by funds: $84M → $25.9M (-$58.1M)
73% less call options, than puts
Call options by funds: $35K | Put options by funds: $129K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCM
Highbridge Capital Management
New York
|
+$503K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$479K |
| 3 |
Walleye Capital
New York
|
+$448K |
| 4 |
BlackRock
New York
|
+$251K |
| 5 |
Mariner
Overland Park,
Kansas
|
+$194K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$8.28M |
| 2 |
LNWTC
Laird Norton Wetherby Trust Company
Seattle,
Washington
|
-$2.19M |
| 3 |
JP Morgan Chase
New York
|
-$518K |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$353K |
| 5 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
-$271K |
GMDA Hedge Fund Activity: Q2 2022 in Review
57 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Gamida Cell Ltd. Ordinary Shares (GMDA) for Q2 2022, worth a combined $25.9M — down 69% from $84M a quarter earlier.
Fund positioning in GMDA was balanced in Q2 2022: 8 funds opened new positions, 8 closed out, 14 added to existing stakes and 13 trimmed.
The largest buyer was Highbridge Capital Management, adding an estimated $503K. The largest seller was Federated Hermes, cutting an estimated $8.28M.
- 57 institutional investors held Gamida Cell Ltd. Ordinary Shares (GMDA) as of Q2 2022, down from 59 in Q1 2022.
- Funds reported $25.9M of Gamida Cell Ltd. Ordinary Shares stock for Q2 2022, down 69% quarter-over-quarter.
- 8 funds opened new Gamida Cell Ltd. Ordinary Shares positions in Q2 2022 and 8 closed out, a net change of 0 holders.
- The largest Gamida Cell Ltd. Ordinary Shares buyer in Q2 2022 was Highbridge Capital Management, an estimated $503K added.
- The largest Gamida Cell Ltd. Ordinary Shares seller in Q2 2022 was Federated Hermes, an estimated $8.28M sold.
Based on aggregated 13F filings for Q2 2022.